We are live on
!
Find out more
VAM
Visium Asset Management Portfolio holdings
AUM
$1.43B
1-Year Est. Return
3.58%
This Fund
S&P 500
This Quarter
Est. Return
+13.68%
1 Year Est. Return
-3.58%
3 Year Est. Return
+100.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$6.18B
AUM Growth
+$1.08B
(+21%)
Cap. Flow
+$404M
Cap. Flow
% of AUM
6.55%
Top 10 Holdings %
Top 10 Hldgs %
31.51%
Holding
1,163
New
297
Increased
261
Reduced
271
Closed
313
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ENDP
Endo International plc
ENDP
|
+$197M |
| 2 |
AGN
Allergan plc
AGN
|
+$135M |
| 3 |
Bausch Health
BHC
|
+$129M |
| 4 |
CVS Health
CVS
|
+$107M |
| 5 |
McKesson
MCK
|
+$94.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$286M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$225M |
| 3 |
Gilead Sciences
GILD
|
+$86.1M |
| 4 |
Perrigo
PRGO
|
+$79.4M |
| 5 |
Cardinal Health
CAH
|
+$74.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.16% |
| 2 | Consumer Discretionary | 5.06% |
| 3 | Energy | 4.01% |
| 4 | Utilities | 3.23% |
| 5 | Financials | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Canadian National Railway
CNI
$76.9B
| $664K | 0.01% |
+11,800
| New | +$650K |
|
527
Exelon
EXC
$47.2B
| $655K | 0.01% |
27,352
+12,983
| +90% | +$273K |
|
528
State Street Technology Select Sector SPDR ETF
XLK
$115B
| $655K | 0.01% |
+36,000
| New | +$643K |
|
529
ExxonMobil
XOM
$644B
| $655K | 0.01% |
+6,702
| New | +$639K |
|
530
KBR
KBR
$4.62B
| $648K | 0.01% |
24,287
-2,886
| -11% | -$87.1K |
|
|
ETFC
531
DELISTED
E*Trade Financial Corporation
ETFC
| $645K | 0.01% |
27,992
-24,396
| -47% | -$534K |
|
|
BERY
532
DELISTED
Berry Global Group, Inc.
BERY
| $642K | 0.01% |
+30,165
| New | +$646K |
|
533
International Paper
IP
$21.6B
| $638K | 0.01% |
14,879
-17,519
| -54% | -$779K |
|
534
IBM
IBM
$211B
| $637K | 0.01% |
3,459
-318
| -8% | -$56K |
|
535
Core Laboratories
CLB
$488M
| $636K | 0.01% |
+3,200
| New | +$604K |
|
536
Astronics
ATRO
$3.43B
| $635K | 0.01% |
+21,901
| New | +$616K |
|
|
BGC
537
DELISTED
General Cable Corporation
BGC
| $635K | 0.01% |
24,768
+16,959
| +217% | +$491K |
|
538
Canadian Pacific Kansas City
CP
$78.1B
| $632K | 0.01% |
+21,000
| New | +$637K |
|
539
Intercontinental Exchange
ICE
$85.6B
| $631K | 0.01% |
15,930
+4,105
| +35% | +$173K |
|
|
FNSR
540
DELISTED
Finisar Corp
FNSR
| $631K | 0.01% |
+23,796
| New | +$571K |
|
|
TCF
541
DELISTED
TCF Financial Corporation
TCF
| $631K | 0.01% |
+37,840
| New | +$616K |
|
542
Conagra Brands
CAG
$6.94B
| $630K | 0.01% |
26,086
-327,721
| -93% | -$7.86M |
|
543
Cleveland-Cliffs
CLF
$6.57B
| $628K | 0.01% |
30,688
-178
| -0.6% | -$3.68K |
|
|
SPLS
544
DELISTED
Staples Inc
SPLS
| $619K | 0.01% |
54,574
+6,551
| +14% | +$85.6K |
|
545
Oil States International
OIS
$489M
| $615K | 0.01% |
10,911
+5,285
| +94% | +$293K |
|
546
American International
AIG
$41.7B
| $609K | 0.01% |
12,159
-33,065
| -73% | -$1.64M |
|
547
Chipotle Mexican Grill
CMG
$47.2B
| $607K | 0.01% |
53,350
+26,650
| +100% | +$294K |
|
548
Old Republic International
ORI
$10.5B
| $604K | 0.01% |
36,813
+1,070
| +3% | +$17K |
|
549
CF Industries
CF
$19.2B
| $601K | 0.01% |
11,525
-43,850
| -79% | -$2.14M |
|
|
DBD
550
DELISTED
Diebold Nixdorf Incorporated
DBD
| $601K | 0.01% |
15,063
-2,247
| -13% | -$80.9K |
|
Similar funds
FBNAT
CPS
LH
CPM
VFS
ZA
FVFIGP
WA
Visium Asset Management's Q1 2014 Portfolio in Review
As of Q1 2014, Visium Asset Management held 1,163 positions worth $6.18B, up 21% from $5.09B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Visium Asset Management deployed $404M of net new capital in Q1 2014, opening 297 new positions and adding to 261 existing holdings. Its largest new stake was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, down from 54% a quarter earlier, followed by Consumer Discretionary and Energy.
On the sell side, the largest reduction was Allergan Inc, an estimated $286M trimmed.
- Visium Asset Management's largest Q1 2014 buy was Regeneron Pharmaceuticals: 286,563 shares worth $86M.
- Visium Asset Management added most to Endo International plc in Q1 2014, an estimated $197M increase.
- Visium Asset Management's biggest Q1 2014 reduction was Allergan Inc, cutting an estimated $286M.
- Visium Asset Management fully exited Momenta Pharmaceuticals, Inc. in Q1 2014, selling an estimated $64M.
- Visium Asset Management's ten largest holdings make up 32% of its $6.18B portfolio in Q1 2014.
- Visium Asset Management opened 297 new positions and closed 313 in Q1 2014.
- Visium Asset Management's portfolio value rose 21% quarter-over-quarter to $6.18B.
Based on Visium Asset Management's 13F filing for Q1 2014, filed 15 May 2014.